SPL 9.20% 9.5¢ starpharma holdings limited

Value - a tough one to work out, page-22

  1. 54 Posts.
    I am not 100% sure about DEP DOX, but DEP-irinotecan (DEP SN-38) is clear in close cooperation with AS. I posted the paper that showed AS team (not starpharma) is actually on the way of dosing and methods optimization on the preclinical trial in the end of last year.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.008(9.20%)
Mkt cap ! $39.14M
Open High Low Value Volume
9.0¢ 9.5¢ 8.8¢ $334.2K 3.710M

Buyers (Bids)

No. Vol. Price($)
2 50354 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 22908 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.